Hemangiomas and homeobox gene expression

Journal of Craniofacial Surgery

Volumn 17, Issue 4, 2006, Pages 767-771

  Hansen, Scott L ^a,b   Dosanjh, Amarjit ^b   Young, David M ^a,b   Boudreau, Nancy ^b   Hoffman, William Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Congenital hemangioma; Hemangioma; Homeobox genes

Indexed keywords

ALPHA2A INTERFERON; GLUCOSE TRANSPORTER 1; IMIQUIMOD; LIVER ENZYME; STEROID;

ANGIOGENESIS; ARTERIOVENOUS FISTULA; ARTICLE; BENIGN TUMOR; BODY HEIGHT; CHILDHOOD CANCER; CONGENITAL BLOOD VESSEL MALFORMATION; DNA BINDING; DRUG EFFICACY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HEMANGIOMA; HISTOLOGY; HOMEOBOX; HUMAN; INCIDENCE; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MOON FACE; MYCOSIS; NEUROLOGIC DISEASE; NEUTROPENIA; PERSONALITY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE EFFECT; SPASTICITY; STOMACH IRRITATION; VASCULAR TUMOR; WEIGHT;

CHILD; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; HEMANGIOMA; HOMEODOMAIN PROTEINS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 33746784711     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001665-200607000-00031     Document Type: Article

References (45)

1. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr Scand 1955;44:370-379
2. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-332
3. Lister WA. The natural history of strawberry naevi. Lancet 1938;1:1429-1434
4. Bowers RE, Graham EA, Tominson KM. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-680
5. Simpson JR. Natural history of cavernous hemangiomata. Lancet 1959;2:1057-1059
6. Margileth AM, Museles M. Cutaneous hemangiomas in children. JAMA 1965;194:523-526
7. Mulliken J, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004;50:875-882
8. Berenguer B, Mulliken J, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Ped Devel Pathol 2003;6:495-510
9. Enjolras O, Mulliken J, Boon L, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001;107:1647-1654
10. Ezekowitz A, Mulliken J, Folkman J. Interferon α-2a therapy for life threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463
11. Achauer B, Chang C, VanderKam V. Management of hemangioma of infancy: Review of 245 patients. Plast Reconstr Surg 1997;99:1301-1307
12. Boon LM, Macdonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioms. Plast Reconstr Surg 1999;104:1616-1623
13. Gampper TJ, Morgan RF. Vascular anomalies: hemangiomas. Plast Reconstr Surg 2002;110:572-585
14. Hazen PG, Carney JF, Engstrom CW, et al. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 2005;22:254-256
15. Mulliken JB, Glowaki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-420
16. Chang M. Updated classification of hemangiomas and other vascular anomalies. Lymph Research Biol 2003;1:261-265
17. Sarkar M, Mulliken J, Kozakewich H, et al. Thrombocytopenic coagulopathy (Kasabach-Meritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-1386
18. Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Ped Dermatol 2002;19:5-11
19. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005;58:348-352
20. Blei F, Walter J, Orlow S, Marchuk D. Familial segregation of hemangiomas and vascular malformations as a autosomal dominant trait. Arch Dermatol 1998;134:718-722
21. Boudreau N, Andrews C, Srebrow A, et al. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997;139:257-264
22. Myers C, Charboneau A, Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000;148:343-351
23. Mace K, Hansen S, Myers C, et al. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 2005;118:2567-2577
24. Hansen S, Myers C, Charboneau A, et al. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 2003;163:2421-2431
25. Uyeno L, Newman-Keagle J, Cheung I, et al. HoxD3 expression in normal and impaired wound healing. J Surg Res 2001;100:46-56
26. Hansen S, Young D, Boudreau N. HoxD3 expression and collagen synthesis in diabetic fibroblasts. Wound Rep Reg 2003;11:474-480
27. Boudreau N, Varner J. The homeobox transcription factor Hox D3 promotes integrin α5β1 expression and function during angiogenesis. J Biol Chem 2004;279:4862-4868
28. Myers C, Charboneau A, Cheung I, et al. Sustained expression of homeobox D10 inhibits angiogenesis. Am J Path 2002;161:2099-2109
29. Roads K, Arderiu G, Charboneau A. A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol 2005;3:240-252
30. Desplan C, Theis J, O'Farrel P. The Drosophila developmental gene engrailed encodes a sequence specific DNA binding protein. Nature 1985;318:630-635
31. Gonzalez-Crussi F, Reyes-Mugica M. Cellular hemangiomas (hemangioendotheliomas) in infants; light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol 1991;15:769-778
32. Smoller BR, Apfelberg DB. Infantile (juvenile) capillary hemangioma: A tumor of heterogeneous cellular elements. J Cutan Pathol 1993;20:330-336
33. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763
34. Dosanjh A, Chang J, Bresnick S, et al. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells. J Cutan Pathol 2000;27:441-450
35. Boye E, Yu Y, Paranya G, et al. Clonality and alter behavior of endothelial cell from hemangiomas. J Clin Invest 2001;107:745-752
36. Walter J, North P, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangiomas. Genes Chrom Cancer 2002;33:295-303
37. Walter JW, Blei F, Anderson JL, et al. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999;82:77-83
38. Yu Y, Flint A, Mulliken J, et al. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-1375
39. Gorski DH, Walsh K. The role of Homeobox genes in vascular remodeling and angiogenesis. Circ Res 2000;87:865-872
40. Zhong J, Eliceiri B, Stupack D, et al. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest 2003;112:30-41
41. Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-2364
42. Chang J, Most D, Bresnick S, et al. Proliferative hemangiomas: Analysis of cytokine gene expression and angiogenesis. Plast Recontr Surg 1999;103:1-9
43. Volpert OV, Tolsma SS, Pellerin S, et al. Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 1995;217:326-332
44. Panetti T, Chen H, Misenheimer T, et al. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 1997;129:208-216
45. Park Y, Kang Y, Butterfield J, et al. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol 2004;165:2087-2098